H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 271 000 KRW -2.34% Market Closed
Market Cap: 3T KRW
Have any thoughts about
Hugel Inc?
Write Note

Hugel Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hugel Inc
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
H
Hugel Inc
KOSDAQ:145020
Total Current Liabilities
â‚©52.1B
CAGR 3-Years
11%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Current Liabilities
â‚©2.5T
CAGR 3-Years
37%
CAGR 5-Years
33%
CAGR 10-Years
16%
SK Bioscience Co Ltd
KRX:302440
Total Current Liabilities
â‚©135.6B
CAGR 3-Years
-9%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Total Current Liabilities
â‚©791.1B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
9%
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Current Liabilities
â‚©85.6B
CAGR 3-Years
33%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Current Liabilities
â‚©108.1B
CAGR 3-Years
12%
CAGR 5-Years
79%
CAGR 10-Years
N/A
No Stocks Found

Hugel Inc
Glance View

Market Cap
3T KRW
Industry
Biotechnology

Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2015-12-24. The firm's product portfolio consists of botulinum toxins which used for treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50 unit types, 100 unit types and 200unit types; hyaluronic acid (HA) fillers which used for temporary removal of facial wrinkles including the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A and the chaeum VOLUS 20A; wellages, blue roses and other cosmetics. The firm sells its products in domestic and overseas markets.

Intrinsic Value
251 806.3 KRW
Overvaluation 7%
Intrinsic Value
Price
H

See Also

What is Hugel Inc's Total Current Liabilities?
Total Current Liabilities
52.1B KRW

Based on the financial report for Sep 30, 2024, Hugel Inc's Total Current Liabilities amounts to 52.1B KRW.

What is Hugel Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
17%

Over the last year, the Total Current Liabilities growth was -37%. The average annual Total Current Liabilities growth rates for Hugel Inc have been 11% over the past three years , 17% over the past five years .

Back to Top